Biosense Webster’s market share, alleged tying of new catheter purchases argued before US appeals court
Whether Biosense Webster's mapping system held a market share dominant enough to coerce hospitals into buying new catheters rather than reprocessed catheters was argued before a US court today. Whether Biosense...To view the full article, register now.
Already a subscriber? Click here to view full article